Publicacións nas que colabora con Jacobo Pardo Seco (67)

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  3. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

  4. Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study

    The Lancet Child and Adolescent Health, Vol. 8, Núm. 5, pp. 325-338

  5. Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia

    Genes and Diseases, Vol. 11, Núm. 3

  6. Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain

    Emerging Microbes and Infections

  7. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

  8. Whole exome sequencing identifies new susceptibility candidates underlying community-acquired pneumonia

    Genes and Diseases, Vol. 11, Núm. 6